Levonorgestrel
CHEBI:CHEBI_6443
Chemical Information
- Molecular Formula
- C21H28O2
- Molecular Mass
- 312.44582
- Charge
- 0
- SMILES
- [H][C@]12CCC(=O)C=C1CC[C@]1([H])[C@]2([H])CC[C@@]2(CC)[C@@]1([H])CC[C@@]2(O)C#C
- InChI
- InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1
- InChIKey
- WWYNJERNGUHSAO-XUDSTZEESA-N
Alternative Names
- (-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
- 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
- 13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one
- 13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one
- 17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one
- 17-alpha-Ethynyl-13-ethyl-19-nortestosterone
- 17-Ethynyl-18-methyl-19-nortestosterone
- 17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol
- 17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
- 17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one
- 17alpha-Ethynyl-18-homo-19-nortestosterone
- 18-Methyl-17-alpha-ethynyl-19-nortestosterone
- 18-Methylnorethisterone
- d(-)-Norgestrel
- Jadelle
- Levonelle
- levonorgestrel
- Levonorgestrel
- levonorgestrelum
- Levonova
- Microlut
- Microluton
- Microval
- Mirena
- NorLevo
- Plan B
- Postinor
Treatment Applications
-
vaginal benign neoplasmView Disease →
DOID:0060114
-
vaginal cancerView Disease →
DOID:119
-
vulvar diseaseView Disease →
DOID:2059
-
endocervical carcinomaView Disease →
DOID:7519
-
chronic salpingo-oophoritisView Disease →
DOID:12265
-
vulva cancerView Disease →
DOID:1245
-
chronic salpingitisView Disease →
DOID:5731
-
obsolete metastasis to vaginaView Disease →
DOID:1912
-
fallopian tube cancerView Disease →
DOID:1964
-
obsolete vulvar blue nevusView Disease →
DOID:2085
-
obsolete vulvar metastasisView Disease →
DOID:2100
-
cervix carcinomaView Disease →
DOID:2893
-
cervical adenocarcinomaView Disease →
DOID:3702
-
cervical cancerView Disease →
DOID:4362
-
obsolete vaginal blue nevusView Disease →
DOID:5226
-
cervix small cell carcinomaView Disease →
DOID:6740
-
female urethral cancerView Disease →
DOID:738
-
vaginal tubulovillous adenomaView Disease →
DOID:8104
-
vulva fibroepithelial polypView Disease →
DOID:8255
-
obsolete dysplasia of cervixView Disease →
DOID:8586
-
polyp of corpus uteriView Disease →
DOID:9042
-
obsolete cervix blue nevusView Disease →
DOID:9443
-
cervix squamous papillomaView Disease →
DOID:9445
Drug Classification
-
terminal acetylenic compoundView Class →
CHEBI:73477
-
17beta-hydroxy steroidView Class →
CHEBI:35343
-
3-oxo-Delta(4) steroidView Class →
CHEBI:47909
-
t265168
-
t265569
-
t265881
-
t266043
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:6443
- DRON_00010000
- 6373
- oboInOwl#hasDbXref
- PDBeChem:NOG
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- brand_name_base
- Morning After Pill
- product_ndc
- 73436-2859
- brand_name
- Julie
- marketing_start_date
- 20030411
- labeler_name
- Aurohealth LLC
- dosage_form
- INTRAUTERINE DEVICE
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- application_number
- ANDA079218
- listing_expiration_date
- 20241231
- spl_id
- 056c2ecb-4a90-669d-e063-6294a90a90ba
- package_description
- 3 BLISTER PACK in 1 POUCH (53002-1779-3) / 1 KIT in 1 BLISTER PACK
- package_ndc
- 16714-340-03
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_59826
- unii
- 5W7SIA7YZW
- spl_set_id
- fc5d29bb-4a4b-e61e-e053-6394a90a8a62
- rxcui
- 2644394
- core#notation
- CHEBI:6443
- nui
- N0000175832
- pharm_class_pe
- Inhibit Ovum Fertilization [PE]
- pharm_class
- Progestin-containing Intrauterine Device [EPC]
- active_ingredient_strength
- 52 mg/1
- pharm_class_epc
- Progestin-containing Intrauterine System [EPC]
- pharm_class_moa
- Estrogen Receptor Agonists [MoA]
- active_ingredient_name
- LEVONORGESTREL BUTYRATE
- pharm_class_cs
- Progesterone Congeners [CS]
- upc
- 0303787281533
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 6373
- oboInOwl#hasDbXref
- PDBeChem:NOG
- oboInOwl#id
- CHEBI:6443
- generic_name
- Levonorgestrel 1.5 mg
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- chebi#has_functional_parent
- http://purl.obolibrary.org/obo/CHEBI_7630
- chebi#is_enantiomer_of
- http://purl.obolibrary.org/obo/CHEBI_50900
- package_marketing_start_date
- 11-APR-03
- route
- INTRAUTERINE
- manufacturer_name
- Cadence Health Inc
- has_treatment
- http://purl.obolibrary.org/obo/DOID_4993
- owl#someValuesFrom
- t729650
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_113682
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect27385
- owl#annotatedSource
- t266399